Serum Metabolomics and Proteomics to Study the Antihypertensive Effect of Protein Extracts from Tenebrio molitor .
Roberto StellaCaterina PeggionCaterina BergantinGiancarlo BiancottoMaria FrosiniElena DreassiMichele PellegrinoAnna Maria AloisiFederica PessinaPublished in: Nutrients (2022)
Hypertension is the leading risk factor for premature death worldwide and significantly contributes to the development of all major cardiovascular disease events. The management of high blood pressure includes lifestyle changes and treatment with antihypertensive drugs. Recently, it was demonstrated that a diet supplemented with Tenebrio molitor (TM) extracts is useful in the management of numerous pathologies, including hypertension. This study is aimed at unveiling the underlying mechanism and the molecular targets of intervention of TM dietary supplementation in hypertension treatment by means of proteomics and metabolomics techniques based on liquid chromatography coupled with high-resolution mass spectrometry. We demonstrate that serum proteome and metabolome of spontaneously hypertensive rats are severely altered with respect to their normotensive counterparts. Additionally, our results reveal that a diet enriched with TM extracts restores the expression of 15 metabolites and 17 proteins mainly involved in biological pathways associated with blood pressure maintenance, such as the renin-angiotensin and kallikrein-kinin systems, serin protease inhibitors, reactive oxygen scavenging, and lipid peroxidation. This study provides novel insights into the molecular pathways that may underlie the beneficial effects of TM, thus corroborating that TM could be proposed as a helpful functional food supplement in the treatment of hypertension.
Keyphrases
- blood pressure
- mass spectrometry
- liquid chromatography
- hypertensive patients
- cardiovascular disease
- high resolution mass spectrometry
- heart rate
- physical activity
- randomized controlled trial
- weight loss
- tandem mass spectrometry
- coronary artery disease
- climate change
- gene expression
- poor prognosis
- binding protein
- ms ms
- dna methylation
- ultra high performance liquid chromatography
- genome wide
- cardiovascular events